212 related articles for article (PubMed ID: 30573388)
1. Clinical and prognostic value of
Albano D; Zizioli V; Odicino F; Giubbini R; Bertagna F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(2):87-93. PubMed ID: 30573388
[TBL] [Abstract][Full Text] [Related]
2. Recurrent bladder carcinoma: clinical and prognostic role of 18 F-FDG PET/CT.
Alongi P; Caobelli F; Gentile R; Stefano A; Russo G; Albano D; Baldari S; Gilardi MC; Midiri M
Eur J Nucl Med Mol Imaging; 2017 Feb; 44(2):224-233. PubMed ID: 27565154
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic and prognostic value of 18F-FDG PET/CT in recurrent germinal tumor carcinoma.
Alongi P; Evangelista L; Caobelli F; Spallino M; Gianolli L; Midiri M; Picchio M
Eur J Nucl Med Mol Imaging; 2018 Jan; 45(1):85-94. PubMed ID: 28828589
[TBL] [Abstract][Full Text] [Related]
4. Clinical and Prognostic Value of
Albano D; Familiari D; Fornito MC; Scalisi S; Laudicella R; Galia M; Grassedonio E; Ruggeri A; Ganduscio G; Messina M; Spada M; Midiri M; Alongi P
Curr Radiopharm; 2020; 13(1):42-47. PubMed ID: 31595860
[TBL] [Abstract][Full Text] [Related]
5. Clinical and prognostic
Albano D; Bonacina M; Savelli G; Ferro P; Busnardo E; Gianolli L; Camoni L; Giubbini R; Bertagna F
Jpn J Radiol; 2022 Jan; 40(1):66-74. PubMed ID: 34272721
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of
Lee JR; Almuhaimid TM; Roh JL; Oh JS; Kim SJ; Kim JS; Choi SH; Nam SY; Kim SY
J Surg Oncol; 2018 Sep; 118(4):644-650. PubMed ID: 30132891
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of the
Yang Y; Pan YQ; Wang M; Gu S; Bao W
Radiat Oncol; 2023 Dec; 18(1):196. PubMed ID: 38049843
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG-PET/CT in laryngeal cancer: comparison with conventional imaging and prognostic role.
Albano D; Dondi F; Paderno A; Nocivelli G; Maddalo M; Magrini SM; Nicolai P; Maroldi R; Giubbini R; Bertagna F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(4):229-238. PubMed ID: 34218885
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of (18)F-FDG PET/CT in restaging patients affected by ovarian carcinoma: a multicentre study.
Caobelli F; Alongi P; Evangelista L; Picchio M; Saladini G; Rensi M; Geatti O; Castello A; Laghai I; Popescu CE; Dolci C; Crivellaro C; Seghezzi S; Kirienko M; De Biasi V; Cocciolillo F; Quartuccio N;
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):404-13. PubMed ID: 26381775
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of FDG PET-derived parameters in preoperative staging of endometrial cancer.
Mapelli P; Bergamini A; Fallanca F; Rancoita PMV; Cioffi R; Incerti E; Rabaiotti E; Petrone M; Mangili G; Candiani M; Gianolli L; Picchio M
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2019; 38(1):3-9. PubMed ID: 30573387
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of metabolic tumor volume and total lesion glycolysis from ¹⁸F-FDG PET/CT in lymph node metastases and risk stratification of endometrial carcinoma.
Liu DD; Li J; Li X; Xie L; Qin L; Peng F; Cheng MH
J Gynecol Oncol; 2019 Nov; 30(6):e89. PubMed ID: 31576685
[TBL] [Abstract][Full Text] [Related]
12. Prognostic role of baseline
Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
14. Clinical utility of F-18 FDG PET/CT in recurrent breast carcinoma.
Manohar K; Mittal BR; Senthil R; Kashyap R; Bhattacharya A; Singh G
Nucl Med Commun; 2012 Jun; 33(6):591-6. PubMed ID: 22334135
[TBL] [Abstract][Full Text] [Related]
15.
García-Talavera P; Alejo E; Arias P; Verdú A; Tamayo P; Gómez-Caminero F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2021; 40(4):207-213. PubMed ID: 34218882
[TBL] [Abstract][Full Text] [Related]
16. Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT.
Alongi P; Picchio M; Zattoni F; Spallino M; Gianolli L; Saladini G; Evangelista L
Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):464-73. PubMed ID: 26268680
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of preoperative metabolic tumor volume measured by ¹⁸F-FDG PET/CT and MRI in patients with endometrial cancer.
Chung HH; Lee I; Kim HS; Kim JW; Park NH; Song YS; Cheon GJ
Gynecol Oncol; 2013 Sep; 130(3):446-51. PubMed ID: 23791826
[TBL] [Abstract][Full Text] [Related]
18. Use of semiquantitative analysis in local recurrence of colorectal carcinoma with
Gedik GK; Yilmaz F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(6):366-372. PubMed ID: 30193775
[TBL] [Abstract][Full Text] [Related]
19. A systematic review about the role of preoperative
Noriega-Álvarez E; García Vicente AM; Jiménez Londoño GA; Martínez Bravo WR; González García B; Soriano Castrejón ÁM
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2023; 42(1):24-32. PubMed ID: 34172434
[TBL] [Abstract][Full Text] [Related]
20. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
